Thus, β-catenin activation and subsequent fibronectin deposition in response to TGF-β1 is enhanced in lung fibroblasts from COPD patients compared to lung fibroblasts from controls. This evidence concerns the gene TGFB1 and chronic obstructive pulmonary disease.